Targeting Amino Acid Metabolism for Molecular Imaging of Inflammation Early After Myocardial Infarction
Open Access
- 1 January 2016
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 6 (11) , 1768-1779
Abstract
Acute tissue inflammation after myocardial infarction influences healing and remodeling and has been identified as a target for novel therapies. Molecular imaging holds promise for guidance of such therapies. The amino acid 11C-methionine is a clinically approved agent which is thought to accumulate in macrophages, but not in healthy myocytes. We assessed the suitability of positron emission tomography (PET) with 11C-methionine for imaging post-MI inflammation, from cell to mouse to man. Uptake assays demonstrated 7-fold higher 11C-methionine uptake by polarized pro-inflammatory M1 macrophages over anti-inflammatory M2 subtypes (p11C-methionine PET was performed 3, 5 and 7d later. MI mice exhibited a perfusion defect in 32-50% of the left ventricle (LV). PET detected increased 11C-methionine accumulation in the infarct territory at 3d (5.9±0.9%ID/g vs 4.7±0.9 in remote myocardium, and 2.6±0.5 in healthy mice; p11C-methionine uptake was associated with macrophage infiltration of damaged myocardium. Treatment with anti-integrin antibodies (anti-CD11a, -CD11b, -CD49d; 100µg) lowered macrophage content by 56% and 11C-methionine uptake by 46% at 3d post-MI. A patient study at 3d after ST-elevation MI and early reperfusion confirmed elevated 11C-methionine uptake in the hypoperfused myocardial region. Targeting of elevated amino acid metabolism in pro-inflammatory M1 macrophages enables PET imaging-derived demarcation of tissue inflammation after MI. 11C-methionine-based molecular imaging may assist in the translation of novel image-guided, inflammation-targeted regenerative therapies.Keywords
This publication has 42 references indexed in Scilit:
- Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac SarcoidosisClinical Nuclear Medicine, 2016
- Clinically relevant strategies for lowering cardiomyocyte glucose uptake for 18F-FDG imaging of myocardial inflammation in miceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Characterizing the Inflammatory Tissue Response to Acute Myocardial Infarction by Clinical Multimodality Noninvasive ImagingCirculation: Cardiovascular Imaging, 2014
- Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarctionJournal of Molecular and Cellular Cardiology, 2014
- Detection of glioma recurrence by 11C-methionine positron emission tomography and dynamic susceptibility contrast-enhanced magnetic resonance imagingNuclear Medicine Communications, 2013
- Image-guided therapies for myocardial repair: concepts and practical implementationEuropean Heart Journal - Cardiovascular Imaging, 2013
- Comparison of Contrast Agents for Atherosclerosis Imaging Using Cultured Macrophages: FDG Versus Ultrasmall Superparamagnetic Iron OxideJournal of Nuclear Medicine, 2013
- Value of 11C-methionine PET in imaging brain tumours and metastasesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Impact of animal handling on the results of 18F-FDG PET studies in mice.2006
- Estimation of internal absorbed dose of l -[methyl- 11 C]methionine using whole-body positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998